Kamyar Kalantar-Zadeh M.D. to Calcitriol
This is a "connection" page, showing publications Kamyar Kalantar-Zadeh M.D. has written about Calcitriol.
Connection Strength
1.342
-
Successful Conversion From Parenteral Paricalcitol to Pulse Oral Calcitriol for the Management of Secondary Hyperparathyroidism in Hemodialysis Patients. J Ren Nutr. 2016 07; 26(4):265-9.
Score: 0.504
-
Association of activated vitamin D treatment and mortality in chronic kidney disease. Arch Intern Med. 2008 Feb 25; 168(4):397-403.
Score: 0.288
-
Survival differences between activated injectable vitamin D2 and D3 analogs. Kidney Int. 2007 Apr; 71(8):827; author reply 827-8.
Score: 0.270
-
Parenteral iron therapy and phosphorus homeostasis: A review. Am J Hematol. 2021 05 01; 96(5):606-616.
Score: 0.177
-
Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals. Kidney Int Suppl. 2010 Aug; (117):S10-21.
Score: 0.085
-
Management of secondary hyperparathyroidism in stages 3 and 4 chronic kidney disease. Endocr Pract. 2008 Jan-Feb; 14(1):18-27.
Score: 0.018